Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20150622022869N9
IRCT20150622022869N9
Completed
Phase 3

Comparison of the effect of interferon-beta 1a and Dexamethasone in hospitalized patients with Covid - 19.

Yasouj University of Medical Sciences0 sites176 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Yasouj University of Medical Sciences
Enrollment
176
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Yasouj University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •Definitive diagnosis of covid\-19 by infectious disease specialist with a positive PCR and spiral ct scan of the lung.
  • •Hospitalized patients who are at least 18 years old.

Exclusion Criteria

  • •Pregnant women
  • •Patients with GFR less than 30%.
  • •Patient with a history of Pancytopenia.
  • •Increased ALT more than 10 times.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
Comparison of the effect of interferon alfa 2 b (IFN-a2b) drops with mitomycin c during surgery on pterygium recurrence in pterygium surgeryPterygium.Pterygium of eyeH11.0
IRCT20160919029871N5Rasht University of Medical Sciences58
Recruiting
Phase 3
Efficacy and safety of Interferon beta-1-a in mild to moderate COVID-19
IRCT20120703010178N25Shahid Beheshti University of Medical Sciences100
Active, not recruiting
Not Applicable
The effect of interferon beta-1a treatment on adaptability of the brain in patients with MSMultiple sclerosisMedDRA version: 14.0Level: PTClassification code 10004504Term: Beta interferon therapySystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Diseases [C] - Nervous System Diseases [C10]
EUCTR2011-003570-89-NLVU University Medical Center
Recruiting
Phase 3
ReciGen for treatment of Covid-19Covid 19.COVID-19, virus identifiedU07.1
IRCT20150914024017N1Tehran University of Medical Sciences40
Recruiting
Phase 2
Evaluation of the effect of Interferon Alfa-2b in diabetic macular edemaDiabetic macular edema.unspecified diabetic retinopathy with macular edemaE11. 311
IRCT20230103057035N1Shahid Beheshti University of Medical Sciences49